Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07556159 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice

Study acronym: AIRITY
StatusRecruiting
PhaseNot specified
SponsorSanofi
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Trial sites expanded: 62 → 71 locations
  2. Minor Eligibility criteria expanded, about 18 words Secondary endpoints: details revised at 9 of 21 entries · Site details revised at 56 of 62 sites Show 2 more changesShow less
    • Secondary endpoints: details revised at 9 of 21 entries
    • Site details revised at 56 of 62 sites
  3. Minor Trial sites expanded: 59 → 62 locationsv4
  4. Minor Trial sites expanded: 54 → 59 locationsv3
  5. Minor Trial sites expanded: 4 → 54 locationsv2
  6. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
284 trials monitored
See 12 trials at risk
927 trials monitored
See 32 trials at risk
The main aim of the study to describe the characteristics of participants with asthma across the spectrum of disease severity, including sociodemographic and clinical characteristics, treatment and disease burden, biomarkers, and both disease-specific and generic health-related quality of life. The study consists of two parts: a cross-sectional study, and a prospective follow-up evaluate changes in disease trajectories in participants with asthma.
Trial Details
NCT Number NCT07556159
Lead Sponsor Sanofi
Collaborators: Syneos Health
Conditions Asthma
Enrollment 2,500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov